The topical scar treatment market in Canada is expected to reach a projected revenue of US$ 148.2 million by 2033. A compound annual growth rate of 10.2% is expected of Canada topical scar treatment market from 2026 to 2033.
The Canada topical scar treatment market generated a revenue of USD 68.5 million in 2025 and is expected to reach USD 148.2 million by 2033.
The Canada market is expected to grow at a CAGR of 10.2% from 2026 to 2033.
In terms of segment, creams was the largest revenue generating product in 2025.
Silicon Sheets is the most lucrative product segment registering the fastest growth during the forecast period.
Topical scar treatment market data book summary
Market revenue in 2025
USD 68.5 million
Market revenue in 2033
USD 148.2 million
Growth rate
10.2% (CAGR from 2026 to 2033)
Largest segment
Creams
Fastest growing segment
Silicon Sheets
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Creams, Gels, Silicon Sheets
Key market players worldwide
Smith & Nephew PLC, Lumenis, Merz Pharma, Sonoma Pharmaceuticals Inc, Cynosure, CCA Industries Inc, Newmedical, Molnlycke Health Care, Suneva Medical, Pacific World Corporation, Perrigo Co PLC, Enaltus, SCAR
Other key industry trends
In terms of revenue, Canada accounted for 3.6% of the global topical scar treatment market in 2025.
Country-wise, China is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. topical scar treatment market is projected to lead the regional market in terms of revenue in 2033.
U.S. is the fastest growing regional market in North America and is projected to reach USD 874.5 million by 2033.
The Canada topical scar treatment market is expanding, partly due to the high prevalence of road accidents, which often result in scarring from injuries. According to a 2023 report by the International Transport Forum, Canada experienced 1,934 road accident fatalities in 2022, marking a 9.4% increase from the previous year and the second-highest death toll in a decade.
In response, innovation and clinical research are driving advancements in topical scar treatments. Companies are investing in clinically tested formulations that incorporate advanced ingredients like silicone-based gels, growth factors, and mineral sunscreens to improve scar healing and reduce visibility.
In January 2021, Vancouver-based BirchBioMed Inc. announced statistically significant, positive outcomes from a double-blind study evaluating the safety and effectiveness of its topical FS2 treatment for keloid scars. FS2, the active ingredient in BirchBioMed's FS2 cream, has demonstrated an ability to inhibit collagen formation, a key factor in scar development.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Topical scar treatment market will help companies and investors design strategic landscapes.
Creams was the largest segment with a revenue share of 39.56% in 2025.
Horizon Databook has segmented the Canada topical scar treatment market based on creams, gels, silicon sheets covering the revenue growth of each sub-segment from 2021 to 2033.
The Canada topical scar treatment market is expanding, partly due to the high prevalence of road accidents, which often result in scarring from injuries. According to a 2023 report by the International Transport Forum, Canada experienced 1,934 road accident fatalities in 2022, marking a 9.4% increase from the previous year and the second-highest death toll in a decade.
In response, innovation and clinical research are driving advancements in topical scar treatments. Companies are investing in clinically tested formulations that incorporate advanced ingredients like silicone-based gels, growth factors, and mineral sunscreens to improve scar healing and reduce visibility.
In January 2021, Vancouver-based BirchBioMed Inc. announced statistically significant, positive outcomes from a double-blind study evaluating the safety and effectiveness of its topical FS2 treatment for keloid scars. FS2, the active ingredient in BirchBioMed's FS2 cream, has demonstrated an ability to inhibit collagen formation, a key factor in scar development.
Canada Topical Scar Treatment Market Product Outlook (Revenue, USD Million , 2021-2033)
Creams
Gels
Silicon Sheets
Others
Canada Topical Scar Treatment Market Scar Type Outlook (Revenue, USD Million , 2021-2033)
Atrophic Scars
Hypertrophic and Keloid Scars
Contracture Scars
Stretch Marks
Canada Topical Scar Treatment Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Online
Reasons to subscribe to topical scar treatment market report databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of topical scar treatment market report databook
Our clientele includes a mix of topical scar treatment market report companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada topical scar treatment market report, including forecasts for subscribers. This country databook contains high-level insights into Canada topical scar treatment market report from 2021 to 2033, including revenue numbers, major trends, and company profiles.